Vimarsana
Biggest News Aggregation in the World

Valeryl Feigin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valeryl Feigin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valeryl Feigin Today - Breaking & Trending Today

Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China - Vimarsana News

Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China

AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set out apriori through hierarchical...

Stroke Mortality Set to Increase to 9.7 Million in 2050 - Vimarsana News

Stroke Mortality Set to Increase to 9.7 Million in 2050

Stroke mortality is projected to increase to 9.7 million deaths by 2050, according to a report issued by the World Stroke Organization.

Stroke Mortality Set to Increase to 9.7 Million in 2050 - Vimarsana News

Stroke Mortality Set to Increase to 9.7 Million in 2050

TUESDAY, Oct. 10, 2023 (HealthDay News) -- Stroke mortality is projected to increase to 9.7 million deaths by 2050, according to a report issued by the World Stroke Organization-Lancet Neurology

Stroke could cause 10 mn deaths annually by 2050: Lancet - Vimarsana News

Stroke could cause 10 mn deaths annually by 2050: Lancet

Stroke could cause nearly 10 million deaths annually by 2050, mostly in low-middle income countries (LMICs), and cost up to $2 trillion per year, according to a global burden of stroke report published in the Lancet Neurology journal.

Source: ummid.com
Pragmatic Solutions to 'Catastrophic' Global Stroke Burden - Vimarsana News

Pragmatic Solutions to 'Catastrophic' Global Stroke Burden

Urgent measures to reduce stroke burden worldwide are needed, with an emphasis on low- and middle-income countries, concludes a report from the World Stroke Organization and the Lancet Neurology Commission.